Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.47
-0.27 (-3.49%)
May 18, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Employees
Aura Biosciences had 113 employees as of December 31, 2025. The number of employees increased by 4 or 3.67% compared to the previous year.
Employees
113
Change (1Y)
4
Growth (1Y)
3.67%
Revenue / Employee
n/a
Profits / Employee
-$994,628
Market Cap
823.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 113 | 4 | 3.67% | 113 | 0 |
| Dec 31, 2024 | 109 | 20 | 22.47% | 106 | 3 |
| Dec 31, 2023 | 89 | 17 | 23.61% | 88 | 1 |
| Dec 31, 2022 | 72 | 20 | 38.46% | 70 | 2 |
| Dec 31, 2021 | 52 | - | - | 52 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Xencor | 260 |
| Kura Oncology | 260 |
| Omeros | 175 |
| Sana Biotechnology | 142 |
| ORIC Pharmaceuticals | 104 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Arbutus Biopharma | 19 |
AURA News
- 6 days ago - Aura Biosciences price target lowered to $17 from $26 at Leerink - TheFly
- 6 days ago - Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 days ago - Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 13 days ago - Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 14 days ago - Aura Biosciences $260M Spot Secondary priced at $6.00 - TheFly
- 14 days ago - Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants - GlobeNewsWire
- 14 days ago - Aura Biosciences announces common stock, pre-funded warrant offering - TheFly
- 14 days ago - Aura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO - TheFly